AB Science ABSCF
Trading Information
- Previous Close Price
- $1.12
- Day Range
- $1.12–1.12
- 52-Week Range
- $1.12–1.45
- Bid/Ask
- $0.00 / $14.00
- Shares Outstanding
- 96.53M
- Market Cap
- $78.15M
- Volume/Avg
- 392 / 483
Key Statistics
- Price/Earnings (Normalized)
- 5,546.94
- Price/Sales
- 51.79
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
AB Science is a clinical-stage pharmaceutical company that has developed a diversified portfolio of medicines targeting unmet medical needs, based on two platforms. Masitinib platform: It is based on masitinib, a selective protein kinase inhibitor in development for neurodegenerative diseases, oncology, & inflammatory diseases. It has the clinical development of masitinib in neurodegenerative diseases (specifically Alzheimer's disease, amyotrophic lateral sclerosis, & progressive forms of multiple sclerosis). ALDH/Microtubule Platform: It is a portfolio of synthetic agents that target cancer cells by destabilising microtubules, which are essential for cell division & cancer stem cells, by inhibiting enzymes that are essential for maintaining their physiological state & survival.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 33
- Website
- https://www.ab-science.com
Valuation
|
Metric
|
ABSCF
|
|---|---|
Price/Earnings (Normalized) | 5,546.94 |
Price/Book Value | — |
Price/Sales | 51.79 |
Price/Cash Flow | — |
Price/Earnings
ABSCF
Financial Strength
|
Metric
|
ABSCF
|
|---|---|
Quick Ratio | 0.78 |
Current Ratio | 0.85 |
Interest Coverage | −4.38 |
Quick Ratio
ABSCF
Profitability
|
Metric
|
ABSCF
|
|---|---|
Return on Assets (Normalized) | −35.49% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ABSCF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Mc@dN#m | LOCK|vZ$mN | $71B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|m?WLnZw | LOCK|F<p% | $47B | |||
| Haleon PLC ADR
HLN
| LOCK|?n&T^@K | LOCK|wvw | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|NKRk@%J& | LOCK|fv | $34B | |||
| Viatris Inc
VTRS
| LOCK|LV&VdS# | LOCK|W& | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|$? | LOCK|lcj | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|%#C$Qbj | LOCK|q% | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|?h!$%^# | LOCK|@%! | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|%Z>?d& | LOCK|C&&b% | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|gX<v?bn | LOCK|xw | $2B |
United States